FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041055356> ?p ?o ?g. }

• W2041055356 endingPage "40" @default.
• W2041055356 startingPage "33" @default.
• W2041055356 abstract "In Brief Objective The aims of this study were to estimate persistence with osteoporosis therapies and to assess persistence by different users (stable and switching), type of osteoporosis drug, and calendar year of initiation among postmenopausal women. Methods This study was conducted using the data from the UK General Practice Research Database. We identified all women in the General Practice Research Database who had a first-ever recording of a prescription for an oral bisphosphonate, oral raloxifene, or oral strontium ranelate between January 1, 1995, and March 31, 2008, and who were 50 years or older or had a diagnosis to indicate menopause at an earlier age. Persistence was estimated as the proportion of women who continued therapy at 6 months and at 1, 3, and 5 years, using Kaplan-Meier methodology. Because women could have multiple episodes (of one or more therapies) over the follow-up period, persistence was evaluated for each individual episode. Results There were 66,116 eligible postmenopausal women who received at least one prescription for one of the osteoporosis therapy drugs in this study during the period 1995 to 2008. Overall, the women were continuing with osteoporosis therapy at 6 months after the index date in the full study population in 44% of episodes and in 32%, 16%, and 9% of episodes at 1, 3, and 5 years later, respectively. Conclusions Persistence with osteoporosis therapies has improved over the study period, but persistence in the first 6 months remains below 50%, leaving a large unmet need to improve the management of postmenopausal women through novel adherence programs and therapies. The results of this study show that with all three compliance measures, the supplements were the treatment yielding the lowest percentage of good compliers. Combining objective and self-reported compliance, 29.5% of the women did not adequately comply with antiresorptive therapy, and 56% did not adequately comply with dietary supplements." @default.
• W2041055356 created "2016-06-24" @default.
• W2041055356 creator A5013374962 @default.
• W2041055356 creator A5014718244 @default.
• W2041055356 creator A5025121087 @default.
• W2041055356 creator A5056751707 @default.
• W2041055356 creator A5058965019 @default.
• W2041055356 creator A5072428628 @default.
• W2041055356 creator A5076406808 @default.
• W2041055356 date "2012-01-01" @default.
• W2041055356 modified "2023-10-16" @default.
• W2041055356 title "Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database" @default.
• W2041055356 cites W1691887444 @default.
• W2041055356 cites W1984754135 @default.
• W2041055356 cites W1985327136 @default.
• W2041055356 cites W1994046647 @default.
• W2041055356 cites W1996239854 @default.
• W2041055356 cites W2006452622 @default.
• W2041055356 cites W2026344725 @default.
• W2041055356 cites W2052539567 @default.
• W2041055356 cites W2074724534 @default.
• W2041055356 cites W2103058568 @default.
• W2041055356 cites W2127598966 @default.
• W2041055356 cites W2133900873 @default.
• W2041055356 cites W2136950115 @default.
• W2041055356 cites W2141336118 @default.
• W2041055356 cites W2143282696 @default.
• W2041055356 cites W2147434484 @default.
• W2041055356 cites W2157604999 @default.
• W2041055356 cites W2167560032 @default.
• W2041055356 doi "https://doi.org/10.1097/gme.0b013e318221bacd" @default.
• W2041055356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21926926" @default.
• W2041055356 hasPublicationYear "2012" @default.
• W2041055356 type Work @default.
• W2041055356 sameAs 2041055356 @default.
• W2041055356 citedByCount "45" @default.
• W2041055356 countsByYear W20410553562013 @default.
• W2041055356 countsByYear W20410553562014 @default.
• W2041055356 countsByYear W20410553562015 @default.
• W2041055356 countsByYear W20410553562016 @default.
• W2041055356 countsByYear W20410553562017 @default.
• W2041055356 countsByYear W20410553562018 @default.
• W2041055356 countsByYear W20410553562019 @default.
• W2041055356 countsByYear W20410553562020 @default.
• W2041055356 countsByYear W20410553562021 @default.
• W2041055356 countsByYear W20410553562022 @default.
• W2041055356 countsByYear W20410553562023 @default.
• W2041055356 crossrefType "journal-article" @default.
• W2041055356 hasAuthorship W2041055356A5013374962 @default.
• W2041055356 hasAuthorship W2041055356A5014718244 @default.
• W2041055356 hasAuthorship W2041055356A5025121087 @default.
• W2041055356 hasAuthorship W2041055356A5056751707 @default.
• W2041055356 hasAuthorship W2041055356A5058965019 @default.
• W2041055356 hasAuthorship W2041055356A5072428628 @default.
• W2041055356 hasAuthorship W2041055356A5076406808 @default.
• W2041055356 hasConcept C121608353 @default.
• W2041055356 hasConcept C126322002 @default.
• W2041055356 hasConcept C127413603 @default.
• W2041055356 hasConcept C187212893 @default.
• W2041055356 hasConcept C187320778 @default.
• W2041055356 hasConcept C2426938 @default.
• W2041055356 hasConcept C2776541429 @default.
• W2041055356 hasConcept C2776594446 @default.
• W2041055356 hasConcept C2776886416 @default.
• W2041055356 hasConcept C2778562196 @default.
• W2041055356 hasConcept C2779889926 @default.
• W2041055356 hasConcept C2781009140 @default.
• W2041055356 hasConcept C2908647359 @default.
• W2041055356 hasConcept C3018571302 @default.
• W2041055356 hasConcept C41008148 @default.
• W2041055356 hasConcept C530470458 @default.
• W2041055356 hasConcept C71924100 @default.
• W2041055356 hasConcept C77088390 @default.
• W2041055356 hasConcept C84606932 @default.
• W2041055356 hasConcept C98274493 @default.
• W2041055356 hasConcept C99454951 @default.
• W2041055356 hasConceptScore W2041055356C121608353 @default.
• W2041055356 hasConceptScore W2041055356C126322002 @default.
• W2041055356 hasConceptScore W2041055356C127413603 @default.
• W2041055356 hasConceptScore W2041055356C187212893 @default.
• W2041055356 hasConceptScore W2041055356C187320778 @default.
• W2041055356 hasConceptScore W2041055356C2426938 @default.
• W2041055356 hasConceptScore W2041055356C2776541429 @default.
• W2041055356 hasConceptScore W2041055356C2776594446 @default.
• W2041055356 hasConceptScore W2041055356C2776886416 @default.
• W2041055356 hasConceptScore W2041055356C2778562196 @default.
• W2041055356 hasConceptScore W2041055356C2779889926 @default.
• W2041055356 hasConceptScore W2041055356C2781009140 @default.
• W2041055356 hasConceptScore W2041055356C2908647359 @default.
• W2041055356 hasConceptScore W2041055356C3018571302 @default.
• W2041055356 hasConceptScore W2041055356C41008148 @default.
• W2041055356 hasConceptScore W2041055356C530470458 @default.
• W2041055356 hasConceptScore W2041055356C71924100 @default.
• W2041055356 hasConceptScore W2041055356C77088390 @default.
• W2041055356 hasConceptScore W2041055356C84606932 @default.
• W2041055356 hasConceptScore W2041055356C98274493 @default.
• W2041055356 hasConceptScore W2041055356C99454951 @default.
• W2041055356 hasIssue "1" @default.

• next